Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma

BACKGROUND: Although there have been indirect comparisons of the relative efficacy of mepolizumab (anti-IL-5) and benralizumab (anti-IL-5Rα) in severe asthma patients, long-term direct head-to-head comparisons are lacking. Here, we (i) examined the effect of mepolizumab, benralizumab, and omalizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: AlShareef, Saad, McDonald, Christine F, Lee, Joy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857973/
https://www.ncbi.nlm.nih.gov/pubmed/35210787
http://dx.doi.org/10.2147/JAA.S348137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857973/
https://www.ncbi.nlm.nih.gov/pubmed/35210787
http://dx.doi.org/10.2147/JAA.S348137

Ejemplares similares